When research peptides and small molecules are reconstituted in bacteriostatic water containing 0.9% benzyl alcohol — benzyl alcohol, the standard bacteriostatic preservative, not the industrial compound benzoyl alcohol it is often confused with — their degradation timelines track structural complexity far more closely than they track price or provenance.
Every figure in this reference assumes a controlled baseline:
- Constant refrigeration at 2–8°C
- Strict protection from UV and ambient light
- No aggressive agitation, shaking, or repeated warming
Change any one of those and the curve steepens. And regardless of measured chemical purity, the 28-day sterility rule remains the limiting factor for any multi-dose vial: the preservative's ability to suppress bacterial growth degrades after the first needle puncture, so sterility — not potency — sets the practical endpoint.
How to read the chart
The table groups 26 compounds into four categories by structural resilience and shows estimated High-Performance Liquid Chromatography (HPLC) purity and potency trends at 30, 60 and 90 days post-reconstitution. The final column names the dominant chemical failure mode — knowing how something fails is more useful than knowing when, because it tells you which handling variable matters most.
The 26-compound potency master timeline
Category 1: Maximum stability (ultra-resilient)
Minimal cleavage points or protected ends.
| Compound | 30-Day | 60-Day | 90-Day | Primary failure driver |
|---|---|---|---|---|
| KPV | 98% | 90% | 85% | Tiny 3-amino-acid chain; few bonds to split |
| Melanotan 2 | 98% | 90–92% | 80–85% | Cyclic structure strongly resists hydrolysis |
| PT-141 | 98% | 90–92% | 80–85% | Highly stable cyclized core |
| SS-31 (Elamipretide) | 97% | 88–90% | 80–85% | Small tetrapeptide; engineered with D-amino acids |
| Epithalon | 96% | 88% | 80% | Short, simple 4-amino-acid chain |
| Pinealon | 96% | 88% | 80% | Tiny, highly resilient 3-amino-acid chain |
| 5-Amino-1MQ | 96–98% | 88–90% | 75–80% | Small molecule; highly light-sensitive |
Category 2: Moderate stability (standard linear)
Steady aqueous bond cleavage (hydrolysis).
| Compound | 30-Day | 60-Day | 90-Day | Primary failure driver |
|---|---|---|---|---|
| BPC-157 | 95–97% | 82–85% | 80–85% | Highly stable for its size; slow oxidation |
| Selank | 94% | 82% | 72% | 7-amino-acid linear structure; steady hydrolysis |
| Semax | 94% | 82% | 70% | ACTH fragment; decays steadily in water |
| Tirzepatide | 92–95% | 80–84% | 70–75% | Long lipidated backbone lacks commercial stabilizers |
| Retatrutide | 92–95% | 80–84% | 70–75% | Triple-agonist chain subject to standard cleavage |
| Cagrilintide | 92–95% | 80–82% | 70% | Amylin analog; undergoes slow aggregation |
| Ipamorelin | 93–95% | 80–83% | 70–75% | Clean pentapeptide; predictable degradation curve |
| Kisspeptin-10 | 92–94% | 78–82% | 70% | Active fragment; short-term stability is reliable |
| Kisspeptin-54 | 90% | 72% | 60% | Full parent molecule; degrades much faster |
| Thymosin Alpha 1 | 90–93% | 75–80% | 65–70% | 28-amino-acid chain prone to deamidation |
Category 3: Rapid collapse (fragile / highly reactive)
Rapid oxidation, clumping, or structural flattening.
| Compound | 30-Day | 60-Day | 90-Day | Primary failure driver |
|---|---|---|---|---|
| GHK-Cu | 85–88% | 65–70% | < 50% | Copper ion catalyzes destructive oxidation |
| TB-500 (Fragment 17-23) | 85–88% | 65–70% | < 60% | Shorter fragment; holds up better than full protein |
| Thymosin Beta-4 (full) | 82–85% | 60–65% | < 50% | 43-amino-acid chain; oxidation-prone methionine |
| MOTS-c | 80–85% | < 65% | < 55% | Mitochondrial peptide; rapid aggregation |
| Oxytocin | 80–83% | < 60% | < 50% | Disulfide bridges rapidly mismatch in solution |
| Tesamorelin | 80–84% | 60–65% | < 55% | Large 44-amino-acid GHRH; structurally collapses |
| CJC-1295 (no DAC) | 80–84% | < 60% | < 50% | Extreme aqueous sensitivity; cleaves apart rapidly |
Category 4: Highly soluble biomolecules (non-peptides)
Vulnerable to ambient oxygen degradation.
| Compound | 30-Day | 60-Day | 90-Day | Primary failure driver |
|---|---|---|---|---|
| Glutathione | 95% | 75% | < 60% | Reactive antioxidant; converts rapidly to oxidized GSSG |
| NAD+ | 95% | 70% | < 55% | Unstable in water; hydrolyzes down to nicotinamide |
Key structural insights from the data
1. The oxidation traps. Glutathione, Thymosin Beta-4, and GHK-Cu degrade less from simple water-driven cleavage and more from oxidative reactions. GHK-Cu's copper ion actively accelerates its own breakdown, and glutathione effectively sacrifices itself soaking up whatever microscopic oxygen remains inside the vial — spent long before the solution looks any different.
2. Size versus survival. The contrast between Kisspeptin-10 and Kisspeptin-54 illustrates the core rule: longer chains present more vulnerability points for hydrolysis. That is why small structures like KPV, Epithalon, and Pinealon hold up for months while Tesamorelin and CJC-1295 fall apart within weeks.
3. The preservative reality check. Even where a compound like Melanotan 2 or SS-31 still measures 85% HPLC purity at day 90, that number does not make the vial usable as a multi-dose preparation. Benzyl alcohol is validated to maintain sterile integrity for roughly 28 days post-puncture; past that window the solution is an unvalidated contamination risk no matter how clean the chromatogram looks.
What this means for planning volumes
The practical takeaway is to size reconstitution volumes to the 30-day window rather than to the vial. If a protocol consumes a vial slowly, a smaller reconstitution volume with a higher concentration — or splitting material across sterile aliquots — keeps material inside its peak stability band instead of stretching a single punctured vial across 90 days.
Run the numbers with our reconstitution calculator, map a full schedule with the protocol builder, or check the nasal equivalent with the intranasal calculator. The broader handling protocol sits in our reconstitution and storage guide, and per-compound schedules live in the dosage protocol directory.
Source and scope
Figures are compiled from an aggregated potency reference chart covering 26 reconstituted compounds in bacteriostatic water with 0.9% benzyl alcohol under refrigerated, light-protected storage. They represent estimated degradation trends for reference and comparison, not lot-specific analytical results. Verify any specific lot against its own certificate of analysis and confirm identity by mass spectrometry before quantitative work.
Frequently asked questions
How long does a reconstituted peptide stay potent?
It depends on structure. Small, cyclic, or protected sequences such as KPV, PT-141, and Melanotan 2 typically hold 90%+ at 60 days refrigerated, while fragile compounds like CJC-1295 (no DAC), oxytocin, and NAD+ can fall below 60% by day 60.
Why is 28 days the limit even when potency is still high?
Because benzyl alcohol in bacteriostatic water is only validated to inhibit bacterial growth for about 28 days after the first needle puncture. Sterility, not chemical purity, is the limiting safety factor for a multi-dose vial.
Is it benzyl alcohol or benzoyl alcohol?
Benzyl alcohol. Bacteriostatic water is preserved with 0.9% benzyl alcohol. Benzoyl compounds are a different chemical class and are not the preservative used here.
Which compounds degrade fastest in solution?
CJC-1295 (no DAC), oxytocin, tesamorelin, MOTS-c, full-length Thymosin Beta-4, GHK-Cu, NAD+, and glutathione — driven by oxidation, disulfide mismatching, or aggregation rather than slow hydrolysis alone.
Does refrigeration change these numbers?
Yes. Every figure assumes constant 2–8°C storage, protection from UV and ambient light, and no aggressive agitation. Room-temperature storage, light exposure, or shaking accelerate degradation well beyond the trends shown.
Why does GHK-Cu degrade faster than similar-sized peptides?
The copper ion bound to the tripeptide acts as a catalyst for oxidative reactions, so it accelerates its own breakdown independently of chain length.